Stremitzer, S
Sunakawa, Y
Zhang, W
Yang, D
Ning, Y
Stintzing, S
Sebio, A
Yamauchi, S
Matsusaka, S
El-Khoueiry, R
Stift, J
Wrba, F
Gruenberger, T
Lenz, H-J
Article History
Received: 10 September 2014
Revised: 5 December 2014
Accepted: 28 January 2015
First Online: 10 March 2015
Competing interests
: TG is a member of the advisory boards of Roche, Merck-Serono and Sanofi-Aventis (all Vienna, Austria). H-JL is a member of the advisory board of Genentech (San Francisco, CA). The remaining authors declare no conflict of interest.